Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia

Aim This post hoc analysis evaluated the efficacy and safety of intravenous belimumab 10 mg/kg in the South Korean subgroup of patients with systemic lupus erythematosus (SLE) enrolled in the North East Asia (NEA) study (GSK Study BEL113750; NCT01345253). Methods NEA was a double‐blind, placebo‐cont...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of rheumatic diseases 2024-01, Vol.27 (1), p.e14997-n/a
Hauptverfasser:	Suh, Chang‐Hee, Lee, Yoonhee, Yoo, Sang‐Bae, Quasny, Holly, Navarro Rojas, Aldo Amador, Hammer, Anne, Song, Yeong‐Wook, Kang, Young Mo, Cho, Chul‐Soo, Park, Won, Kwok, Seung‐Ki, Lee, Seung‐Geun, Chung, Won Tae, Bae, Sang‐Cheol
Format:	Artikel
Sprache:	eng
Schlagworte:	belimumab efficacy safety South Korea systemic lupus erythematosus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!